MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    DaTscan in clinical evaluation of Multiple System Atrophy

    P. Khemani, S. Vernino (Dallas, TX, USA)

    Objective: To explore accuracy of DaTscanTM Ioflupane I123 Injection (DaTscan) in a multiple system atrophy (MSA) cohort  Background: There are isolated cases of normal DaTscan in neuropathologically confirmed MSA-cerebellar subtype (MSA-C)…
  • 2017 International Congress

    The clinically-available anti-depressant mirtazapine alleviates both psychosis and dyskinesia in the MPTP-lesioned marmoset

    I. Frouni, S. Nuara, N. Veyres, C. Kwan, M.-J. Harraka, V. Nafade, L. Sid-Otmane, J. Gourdon, H. Adjia, P. Huot (Montreal, QC, Canada)

    Objective: To determine the effect of mirtazapine, a clinically-available anti-depressant, on psychosis and dyskinesia in Parkinson’s disease (PD). Background: Psychosis and dyskinesia cause significant morbidity…
  • 2017 International Congress

    Impaired cerebellum to motor cortex associative plasticity in patients with spinocerebellar ataxia type 3

    M.-K. Lu, J.-C. Chen, C.-M. Chen, C.-H. Tsai (Taichung, Taiwan)

    Objective: This study aims to investigate the associative plasticity induced by cerebellum to primary motor cortex (CB-->M1) corticocortical paired associative stimulation (PAS) in patients with…
  • 2017 International Congress

    Dopamine replacement influences on postural motor learning in Parkinson disease

    S. Paul, G. Olivier, C. Walter, S. Schaefer, L. Dibble (Salt Lake City, UT, USA)

    Objective: To determine if i) dopamine replacement affects general and sequence specific learning of a postural task in people with Parkinson disease (PD), and ii)…
  • 2017 International Congress

    Sleep architecture in Parkinson´s disease and Parkinson’s disease associated dementia

    L. Sousa, I. Laranjinha, J. Lopes, J. Ramalheira, A.M. da Silva, A.B. Lima, M. Magalhães (Porto, Portugal)

    Objective: To evaluate the differences in early sleep architecture between patients with Parkinson’s disease (PD) and Parkinson’s disease associated dementia (PDD). Background: Disorders of sleep…
  • 2017 International Congress

    Cognition in the PREDICT-PD Cohort

    A. Nagy, E. Hardaker, J. Bestwick, G. Giovannoni, T. Warner, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To identify whether there is evidence for cognitive dysfunction in participants identified as being at higher risk of Parkinson’s disease (PD) using the PREDICT-PD…
  • 2017 International Congress

    Fluency boost from walking in Parkinson’s disease

    O. Barthelemy, R. Salazar, S. Neargarder, J. DeGutis, T. Ellis, A. Cronin-Golomb (Boston, MA, USA)

    Objective: Examine the impact of a motor task on verbal fluency in individuals with Parkinson’s disease (PD) Background: Dual-tasking, in which individuals engage simultaneously in…
  • 2017 International Congress

    TMEM230 mutation analysis in Parkinson’s disease in a Chinese population

    Z. Liu (Changsha, China)

    Objective: To investigate the prevalence of TMEM230 mutations in Chinese patients with familial and sporadic PD. Background: Recently, Hanxiang Deng and colleagues identified a missense…
  • 2017 International Congress

    SNCA multiplication consortium: Clinicogenetic analysis of SNCA multiplication probands and families.

    A. Book, M. Farrer, T. Candido, I. Guella, D. Evans, E. Gustavsson (Vancouver, BC, Canada)

    Objective: Clinicogenetic analysis of 57 affected probands with SNCA multiplication, 3 unaffected carriers, and their 60 families. To use informative pedigrees to identify penetrance modifiers…
  • 2017 International Congress

    The identification of molecular-genetic background of familial atypical parkinsonism in “Hornacko”, a specific region of the south-eastern Moravia, Czech Republic.

    K. Mensikova, R. Vodicka, K. Kolarikova, T. Bartonikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To assess the genetic background in the pedigrees with identified autosomal-dominant inheritance of parkinsonism. Background: Increased prevalence of parkinsonism with cognitive deterioration was detected…
  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley